Skip to content
Aminoscope
← Research
Peptides

GHRP-2: benefits, risks and what human studies show

GHRP-2 stimulates growth hormone, but human studies do not establish lasting muscle gain, fat loss or anti-aging benefits. Compare measured effects, study limits and FDA safety concerns.

Theo Lindqvist6 min read
GHRP-2: a real growth-hormone pulse that also lifts cortisol and prolactinOne dose, three hormones risethe pulse is not selectivegrowth hormonecortisolprolactinGHRP-2 · GENUINE GH RELEASE, NOT A CLEAN ONE
Need a closer look?Enlarge illustration

GHRP-2 (pralmorelin) is a synthetic ghrelin-receptor agonist that stimulates growth hormone. Human studies establish short-term hormone release and increased appetite; they do not establish lasting muscle gain, fat loss or anti-aging benefits. A diagnostic GH response is not a treatment outcome.

What the human studies measured

Swipe to see all columns

These are hormone and appetite experiments, not trials proving fat loss or muscle gain. Research routes are reported for interpretation, not as dosing instructions.
Study / populationFindingWhat it does not prove
Acute hormone comparison: 6 young and 6 elderly subjects[1]GH rose alongside prolactin, ACTH and cortisolNo long-term muscle, fat or function endpoint
Randomized crossover: n = 7 healthy lean men; subcutaneous infusion[4]Meal intake 9,409 vs 7,118 kJ; +35.9% with GHRP-2One laboratory meal does not establish chronic weight change
Repeated subcutaneous injections: n = 9 healthy subjects, 5 days[5]GH response attenuated; IGF-1 did not increaseToo small and short to establish a long-term benefit or harm
These are hormone and appetite experiments, not trials proving fat loss or muscle gain. Research routes are reported for interpretation, not as dosing instructions.

How GHRP-2 differs from other secretagogues

GHRP-2 activates the growth-hormone secretagogue receptor, also called the ghrelin receptor. GHRH analogs stimulate a separate pathway. Both can affect GH release, but a shared hormone endpoint does not make them interchangeable. Our growth-hormone secretagogue overview explains the difference between the families. The GHRP-6 evidence review covers a related peptide.

Why a GH pulse does not establish muscle gain

Acute stimulation studies show that the pituitary can release GH after exposure. Diagnostic testing uses that response to investigate hormone deficiency; it does not demonstrate that repeated exposure improves a healthy adult’s strength, body composition or lifespan.[3]Older adults with reduced GH secretion have also been studied, including repeated exposure and IGF-1 responses.[2] Those participants should not be relabeled as all having diagnosed GH deficiency, or their findings transferred to healthy athletes.

The five-day experiment is informative but narrow: diminished GH responses and unchanged IGF-1 occurred under that particular regimen.[5] It does not establish that every schedule causes the same response, and it supplies no reason to escalate or combine unapproved peptides. Likewise, increased appetite in the seven-person crossover is a measured short-term effect, not evidence that GHRP-2 will cause a particular amount of weight gain.[4]

Approval, compounding and online products

GHRP-2 is not an FDA-approved treatment for fat loss, muscle building or anti-aging. FDA’s compound-specific safety assessment covers injectable and nasal administration.[6]A prescription or a “research use” label does not establish an online product’s identity, sterility, effectiveness or approval. The peptide access guide explains why drug approval and compounding rules require separate checks.

What to take from the evidence

GHRP-2 has demonstrated endocrine activity. Evidence for a useful chronic treatment is a different question, and the studies summarized here do not answer it for muscle gain, fat loss or longevity. Endocrine symptoms deserve clinical assessment; this evidence review does not supply a self-use protocol. Sermorelin, a GHRH analog that pharmacies can still compound, is the prescription route most telehealth services offer; the Lttl review shows its full price ladder, from $149 for four weeks.

Reviewed against primary sources by the Aminoscope desk

Sources

  1. [1] Arvat E, di Vito L, Maccagno B, Broglio F, Boghen MF, Deghenghi R, Camanni F, Ghigo E. (1997). Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. PMID 9285939
  2. [2] Bowers CY, Granda-Ayala R. (2001). Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion. Endocrine. PMID 11322505
  3. [3] Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Katofor Y; KP-102 Study Group. (2007). A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol. PMID 17609397
  4. [4] Laferrère B, Abraham C, Russell CD, Bowers CY. (2005). Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. PMID 15699539
  5. [5] Nijland EA, Strasburger CJ, Popp-Snijders C, van der Wal PS, van der Veen EA. (1998). A five day treatment with daily subcutaneous injections of growth hormone-releasing peptide-2 causes response attenuation and does not stimulate insulin-like growth factor-I secretion in healthy young men. Eur J Endocrinol. PMID 9820615
  6. [6] U.S. Food and Drug Administration (2026). Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks: GHRP-2 (injectable and nasal routes). FDA. Source

Where to get it

Where to get peptide therapy

Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm GHRP-2 availability before ordering.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Provider reviews we publish: Iron Med RXiThriveMDIvim HealthIvologistIvy RxJently

Compare it

Related tool

Peptide evidence matrix

See every peptide graded by how strong the human evidence actually is — filter by evidence tier, with a primary source on each grade.

More in Peptides